Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK) HKSE

25.72

+0.7(+2.80%)

Updated at September 08 03:40PM

Currency In HKD

Valuation

Market Cap3.18B
Enterprise Value3.37B
P/E Ratio-184.91
PEG Ratio-8.48
Price/Sales Ratio22.88
Price/Book Ratio11.23
Enterprise/Revenue23.35
Enterprise/EBITDA103.05

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.12
Operating Margin0.04

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.07

Income Statement

Revenue980.45M
Revenue/Share1.03
Gross Profit761.52M
EBITDA303.8M
Net Income33.54M
Diluted EPS0.08

Balance Sheet

Total Cash381.18M
Total Cash/Share0.96
Total Debt570.28M
Total Debt/Equity0.68
Current Ratio1.53
Book Value Per Share2.11

Price History

52-Week Change327.95
52-Week High28.58
52-Week Low5.6
Moving Average 50 Days23.06
Moving Average 200 Days14.35

Statistics

Average Volume428,450
Shares Outstanding399.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A